Establishment Labs Holdings Inc
ESTA
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.5B
Close$
$-78.11
189.8% downside
Current Fair Value
189.8% downsideOvervalued by 189.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.50 Billion |
|---|---|
| Enterprise Value | $2.43 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.72 |
| Beta | 1.11 |
| Outstanding Shares | 29,622,101 |
Return
| Return on Equity | -295.85% |
|---|---|
| Return on Assets | -12.46% |
| Return on Invested Capital | -11.13% |
Valuation & Multiples
| P/E Ratio | -57.37 |
|---|---|
| PEG | 162.14 |
| Price to Sales | 12.43 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 10.6 |
| Enterprise Value to EBIT | -81.61 |
| Enterprise Value to Net Income | -56 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.33 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 11, 2026
EPS Estimate
$-0.36
Average shareholder expectationRevenue Estimate
$57.47 M
Average shareholder expectationNext Earnings Call
Expected Date
August 6, 2026
EPS Estimate
$-0.34
Average shareholder expectationRevenue Estimate
$65.77 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.1527▼ 152.74% |
|---|---|
| Total Calls | 2,797,500▲ 121.43% |
| Total Puts | 427,100▼ 79.88% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 90.36%▲ 1.03% |
|---|---|
| Total Invested | $1.52B▼ 21.18% |
| Investors Holding | 1880% |
ESG Score
No data
About Establishment Labs Holdings Inc
521 employees
CEO: Juan Jose Chacon Quiros Establishment Labs Holdings Inc. is a global medical technology company focused on women's health, initially in the breast aesthetics and reconstruction market, by designing, developing, manufacturing and marketing an innovative portfoli...